黛力新治疗脑卒中后抑郁的疗效观察

目的：评价黛力新治疗脑卒中后抑郁症患者的疗效。方法：脑卒中后抑郁症患者80例随机分为两组，即治疗组和对照组各40例，分别给予黛力新和盐酸多塞平治疗6周。采用汉密尔顿抑郁量表（HAMD）对患者治疗前和治疗第2、4、6周末进行评估，同时进行全国第四届脑血管病会议修定的NDS评分标准和Barthel指数（BI）评分。结果：治疗组患者的抑郁症状在第2周就开始明显改善，HAMD评分明显降低（P〈0．05），且比对照组降低更明显（P〈0．05）。HAMD评分在治疗第4、6周进一步明显降低（P〈0．05），且比对照组降低更明显（P〈0．05）。治疗组6周后有效率为87．5％，疗效优于对照组，且不良反应少；治疗组治疗14d、28d的NDS和BI显著改善，与对照组比较差异有统计学意义。结论：对脑卒中后抑郁患者，可以采用黛力新治疗，同时能促进急性脑梗死患者康复。

Clinical observation of therapeutic effects of Dailixin on depression in patient with stroke

Objective： To observe the effects of Dailixin on the post-stroke depression patients. Methods： 80 patients with post-stroke d pression were randomly divided into two groups, therapy group （treated with Dailixin, 40 patients, 6 weeks） and control group （treated with Doxepin, 40 patients, 6 weeks）. Both groups were measured by Hamilton rating scale of depression （HAMD）, Chinese Scale of Clinical Neurological Deficit of Stroke Patients （NDS） and Barthel index （BI） before treatment and after 4 weeks, 6 weeks and 8 weeks. Results： The clinical effects of Dailixin in the treatment was better since the 2th week, the HAMD scores were significantly lower （P〈0.05）, better than that of Doxepin （P〈0.05）. In the 4th, 6th week the HAMD scores were much lower （P〈0.05）, and there were significant differences between the two groups （P〈 0.05）. The therapy group effective power was 97.5% anther 6 weeks, with better curative effect and less adverse effect; the NDS and BI in the therapy group were significantly better than that of Doxepin in the 14th, 28th day. Conclusion： It is indicated that Dailixin can reduce the degree of depression and promote the neurological functional rehabilitation after stroke.